Distribution of the same ingredient across different IDDSI levels (Percentages and frequencies) and statistical significance analysis (Chi-square analysis). by Muxi Chen (9294270)

Subjects:

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…Standardized sleep hygiene education did not produce significant changes in sleep parameters. Our findings indicate fragmented nocturnal sleep in patients with MASLD, characterized by increased wakefulness and reduced sleep efficiency, perceived subjectively as shortened sleep duration and delayed onset. …”

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…Standardized sleep hygiene education did not produce significant changes in sleep parameters. Our findings indicate fragmented nocturnal sleep in patients with MASLD, characterized by increased wakefulness and reduced sleep efficiency, perceived subjectively as shortened sleep duration and delayed onset. …”

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…Standardized sleep hygiene education did not produce significant changes in sleep parameters. Our findings indicate fragmented nocturnal sleep in patients with MASLD, characterized by increased wakefulness and reduced sleep efficiency, perceived subjectively as shortened sleep duration and delayed onset. …”

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…Standardized sleep hygiene education did not produce significant changes in sleep parameters. Our findings indicate fragmented nocturnal sleep in patients with MASLD, characterized by increased wakefulness and reduced sleep efficiency, perceived subjectively as shortened sleep duration and delayed onset. …”

Fig 1 - by Sara Hintze (3216885)

Subjects:

Ethogram describing all outcome measures. by Sara Hintze (3216885)

Subjects:

Characteristics of the study population. by Johannes Nairz (18010746)

Subjects:

Study flow chart. by Johannes Nairz (18010746)

Subjects:

Test apparatus. by Sara Hintze (3216885)

Subjects:

Fig 3 - by Sara Hintze (3216885)

Subjects:

Boxplot mean cfPWV comparisons. by Johannes Nairz (18010746)

Subjects:

A schematic mechanism of 1’,4’-<i>trans</i>-diol-ABA in response to salt stress in rice seedlings. by Yin Jie (21464235)

Subjects:

Effects of clonal integration and <i>Bacillus subtilis</i> on total flavonoids (A, C, E) and chlorogenic acid (B, D, F) of the basal, apical portion, and whole fragment of <i>Glech... by Bing-Nan Zhao (21553401)

Subjects:

Baseline characteristics. by Neng Pan (5262032)

Subjects:

Data ste. by Neng Pan (5262032)

Subjects:

Comparison of post-experimental outcome measures. by Neng Pan (5262032)

Subjects:

Schematic representation of the study protocol. by Neng Pan (5262032)

Subjects:

Comparison of data after the experiment. by Neng Pan (5262032)

Subjects:

Representative liver histology of normal control (A), low-dose Olanzapine (B), negative control (C), test (D), and positive control (E) groups (Hematoxylin and Eosin stain, ×400 ma... by Elsie D. Oduor (22521785)